Variates of Survival in Metastatic Uveal Melanoma
Petra Rietschel(Memorial Sloan Kettering Cancer Center), Paul B. Chapman(Memorial Sloan Kettering Cancer Center), Katherine S. Panageas(Mayo Clinic), Christine Hanlon(Memorial Sloan Kettering Cancer Center), David H. Abramson(Memorial Sloan Kettering Cancer Center), Ami B. Patel(University of Utah)
Cited by 313
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k